Inactive Instrument

News Bayer Aktiengesellschaft Other OTC

Equities

BAYER AG : UBS remains Neutral	05-17	ZD
IQ-AI Unit Delivers Software to Insel Gruppe	05-17	MT
Bayer: elinzanetant data presented at congress	05-17	CF
Bayer’s Menopause Drug Reduces Hot Flashes in Late-stage Studies	05-17	MT
Ag inputs sales seen at good level in the US, not as good in South America	05-16	RE
Bayer to present new data at ASCO	05-16	CF
Bayer Starts Phase I Study with Novel Targeted Radionuclide Therapy 225Ac-Psma-Trillium in Advanced Metastatic Prostate Cancer	05-15	CI
BAYER AG : Barclays remains Neutral	05-15	ZD
Chemical industry sees first rays of hope and becomes more confident for 2024	05-15	DP
BAYER AG : UBS remains Neutral	05-15	ZD
Bayer Launches First-in-Human Study of Prostate Cancer Drug Candidate	05-15	MT
BAYER : As soft as anticipated	05-14
Global markets live: Apple, Sony, Vodafone, Booking, Walmart...	05-14
Bayer Plans More Job Cuts in Push for Fewer Bosses -- Update	05-14	DJ
Transcript : Bayer Aktiengesellschaft, Q1 2024 Earnings Call, May 14, 2024	05-14
Jefferies rates Bayer a 'Hold' - Target 29 euros	05-14	DP
BAYER AG : Gets a Neutral rating from JP Morgan	05-14	ZD
Deutsche Bank Research rates Bayer a 'Hold' - Target 29 euros	05-14	DP
BAYER AG : Deutsche Bank reaffirms its Neutral rating	05-14	ZD
CAC40: little movement on the eve of US inflation	05-14	CF

No results for this search

BAYER : As soft as anticipated

May 14, 2024 at 02:12 pm

Bayer AG: Not out of the woods yet

March 06, 2024 at 10:46 am